These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7413705)

  • 1. [Process for producing fluorescein for injection purposes (author's transl)].
    Friedrich F; Kottke K; Kühmstedt H
    Pharmazie; 1980; 34(5-6):300-1. PubMed ID: 7413705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Demonstration of aqueous veins through injection of fluorescein into the anterior chamber in rabbits (author's transl)].
    Tenner A; Jaeger W; Koch W
    Klin Monbl Augenheilkd; 1974 May; 164(5):628-32. PubMed ID: 4842955
    [No Abstract]   [Full Text] [Related]  

  • 3. Preparation of 99Tcm-MAG3: no confirmation that sodium chloride injections from plastic containers affect radiochemical purity.
    Millar AM; O'Brien LM
    Nucl Med Commun; 1998 May; 19(5):475-7. PubMed ID: 9853337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescein isothiocyanates: improved synthesis and purity. Spectral studies.
    Sinsheimer JE; Jagodić V; Burckhalter JH
    Anal Biochem; 1974 Jan; 57(1):227-31. PubMed ID: 4817499
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biological products' specific problems (author's transl)].
    Beys-L'Hoest
    J Pharm Belg; 1977; 32(5):495-515. PubMed ID: 609037
    [No Abstract]   [Full Text] [Related]  

  • 6. [Limulus test for the control of water and materials used in injectables (author's transl)].
    Rinjard P
    J Pharm Belg; 1979; 34(3):168-9. PubMed ID: 480126
    [No Abstract]   [Full Text] [Related]  

  • 7. Inactivation and clearance of viruses during the manufacture of high purity factor IX.
    Johnston A; Macgregor A; Borovec S; Hattarki M; Stuckly K; Anderson D; Goss NH; Oates A; Uren E
    Biologicals; 2000 Sep; 28(3):129-36. PubMed ID: 10964439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of chlorinated fluoresceins for labeling proteins.
    Tian M; Wu XL; Zhang B; Li JL; Shi Z
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1977-9. PubMed ID: 18308564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic approaches and bio-distribution studies of [11C]methyl-phenidate.
    Patt M; Solbach C; Wüllner U; Blocher A; Stahlschmidt A; Gündisch D; Kovar KA; Machulla HJ
    J Pharm Pharm Sci; 2007; 10(2):312s-320s. PubMed ID: 17718934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of 5- and 6-(aminomethyl)fluorescein.
    Mattingly PG
    Bioconjug Chem; 1992; 3(5):430-1. PubMed ID: 1420443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of aminomethyl- and bis-aminomethyl-fluorescein energy transfer terminators.
    Takkellapati SR; Chen CY; Neschadimenko V; Nampalli S; Xiao H; Wegener J; Dhulipala P; Kumar S; Fuller C
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1467-70. PubMed ID: 18066808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gelatine production, the six steps to maximum safety.
    Schrieber R; Seybold U
    Dev Biol Stand; 1993; 80():195-8. PubMed ID: 8270109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Elimination of admixtures from antibiotic sediments during their treatment with solvents].
    Sinitsyn MA; Zhukovskaia SA; Murav'eva SA
    Antibiotiki; 1984 Dec; 29(12):897-901. PubMed ID: 6524891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoenzymatic synthesis of 3'-O-(carboxyalkyl)fluorescein labels.
    Adamczyk M; Grote J; Moore JA
    Bioconjug Chem; 1999; 10(3):544-7. PubMed ID: 10346889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simplified protein precipitation/mixed-mode cation-exchange solid-phase extraction, followed by high-speed liquid chromatography/mass spectrometry, for the determination of a basic drug in human plasma.
    Xue YJ; Akinsanya JB; Liu J; Unger SE
    Rapid Commun Mass Spectrom; 2006; 20(18):2660-8. PubMed ID: 16912986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of a 3'-naphthamido-LacNAc fluorescein conjugate with high selectivity and affinity for galectin-3.
    Aplander K; Tejler J; Toftered J; Carlsson S; Kahl-Knutsson B; Sundin A; Leffler H; Nilsson UJ
    Carbohydr Res; 2006 Jul; 341(10):1363-9. PubMed ID: 16697983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of 99m Tc-MAG3: the effect on radiochemical purity of using sodium chloride injection from plastic ampoules that have been exposed to light.
    Beattie LA; O'Brien LM; Waight CC; Homer NZ; Andrew R; Millar AM
    Nucl Med Commun; 2008 Jul; 29(7):649-53. PubMed ID: 18528188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of HPLC method for the determination of tobramycin in urine samples post-inhalation using pre-column derivatisation with fluorescein isothiocyanate.
    Mashat M; Chrystyn H; Clark BJ; Assi KH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 869(1-2):59-66. PubMed ID: 18502706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric quantitation of nucleoside transporter sites on human leukemic cells.
    Jamieson GP; Brocklebank AM; Snook MB; Sawyer WH; Buolamwini JK; Paterson AR; Wiley JS
    Cytometry; 1993; 14(1):32-8. PubMed ID: 8432200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.